Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Fidrisertib succinate by Ipsen for Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva): Likelihood of Approval
Fidrisertib succinate is under clinical development by Ipsen and currently in Phase II for Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva)....